New treatment tested for common diabetes complication
NCT ID NCT07198516
Summary
This study aims to see if a treatment called Henggliejin can improve fatty liver disease in people who also have type 2 diabetes. It will involve 149 adults who have both conditions and whose blood sugar is not well controlled. Researchers will measure changes in liver health, body fat, and blood sugar levels over 48 weeks to check if the treatment is effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.